Developmental Research Program (DRP)

发展研究计划（DRP）

• 批准号: 10684241
• 负责人: URSULA Anne MATULONIS
• 金额: $ 14.97万
• 依托单位: DANA-FARBER CANCER INST
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-08-03 至 2025-07-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10684241
• 关键词: Advocate; Attention; Award; Budgets; Cancer Center; Complement; Decision Making; Development; Diagnosis; Early Diagnosis; Ensure; Equilibrium; Evaluation; Faculty; Fostering; Funding; Goals; Grant; Institution; Malignant neoplasm of ovary; Mentors; Mentorship; Methods; Minority; Mission; Monitor; Pilot Projects; Prevention; Process; Productivity; Program Research Project Grants; Progress Reports; Reproduction spores; Request for Applications; Research; Research Activity; Research Personnel; Resistance; Resources; Specific qualifier value; Translational Research; Woman; community center; high risk; innovation; novel; programs; research and development; sound; success; synergism; timeline; translational potential

PROJECT SUMMARY/ABSTRACT - DEVELOPMENTAL RESEARCH PROGRAM RESEARCH PLAN The overall goals of the Dana-Farber/Harvard Cancer Center (DF/HCC) Ovarian Cancer SPORE Developmental Research Program (DRP) are to support high risk/high potential pilot projects that take maximum advantage of new research opportunities within the DF/HCC Ovarian Cancer SPORE and to maintain this Program throughout the entire grant term. The selection and monitoring process will be led by the DRP Directors, Drs. Ursula Matulonis, Stephen Cannistra and Alan D’Andrea, with oversight from the other SPORE leader, Dr. Spriggs. The DF/HCC Ovarian Cancer DRP Executive Committee (EC) which is comprised on the DF/HCC SPORE committee, the External Advisory Board, the Internal Advisory Board (IAB) and the Ovarian Cancer Advocate Core of this Ovarian Cancer SPORE Project will directly participate in the review, scoring and selection of DRP Projects. The DRP will encourage applications from minorities and women as well as high risk/high payoff projects. Full access to DF/HCC Ovarian Cancer SPORE resources including Core access will be available to DRP Projects. Those projects that have demonstrated great progress and translational research potential will have the potential to become full SPORE Projects but only with the approval of the DF/HCC Ovarian Cancer DRP EC. Funding for the DRP is comprised partly from the Ovarian Cancer SPORE budget as well as significantly from DF/HCC institutions.

项目摘要/摘要-发展研究计划研究计划 达纳-法伯/哈佛癌症中心(DF/HCC)卵巢癌孢子的总体目标 发展研究计划(DRP)旨在支持高风险/高潜力的试点项目 在DF/HCC卵巢癌孢子内最大限度地利用新的研究机会 在整个资助期内维持本计划。遴选和监测过程将由 DRP主任Ursula Matulonis博士、Stephen Cannstra和Alan D‘Andrea，由另一人监督 孢子领袖斯普里格斯博士。DF/HCC卵巢癌DRP执行委员会(EC)，即 由DF/HCC孢子委员会、外部咨询委员会、内部咨询委员会(IAB)组成 而本次卵巢癌孢子计划的卵巢癌倡导者核心将直接参与 DRP项目的评审、评分和选择。DRP将鼓励少数族裔和 妇女以及高风险/高回报项目。全面获取DF/HCC卵巢癌孢子资源 包括核心访问权限将可用于DRP项目。那些已经证明很棒的项目 进展和翻译研究潜力将有可能成为完整的孢子项目，但只有 经DF/HCC卵巢癌DRP EC批准。DRP的资金部分来自 卵巢癌孢子预算以及来自DF/HCC机构的大量资金。